Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90130276

Filing Date: 08/21/2020

To the Commissioner for Trademarks:

MARK: RESOLUTION (Standard Characters, see mark)
The literal element of the mark consists of RESOLUTION. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Resolution Therapeutics Limited, a private limited company legally organized under the laws of United Kingdom, having an address of
      8 Bloomsbury Street
      London WC1B3SR
      United Kingdom
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 001:  Chemicals for scientific purposes; chemicals for use in research; chemicals, enzymes, DNA and RNA for research use; cells for scientific purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use; Pharmaceutical preparations; medical and veterinary preparations for therapeutic purposes; biological, chemical and biochemical reagents for medical use; cells for medical or veterinary use; preparations for cell therapy; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of cells from humans or animals which have been adapted for medical or therapeutic purposes; Treatment and processing of biological materials; custom manufacture of therapeutic drugs, including custom manufacture of cells and cell therapies; information, advisory and consultancy services in relation to all of the aforesaid services; Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; chemical and biological analysis and research services; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products (for others); scientific laboratory services; advisory and consultancy relating to all the aforesaid services; Medical services; veterinary services; medical services for the treatment of conditions of the human or animal body; services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on United Kingdom application number __________, filed 08/21/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.




The owner's/holder's proposed attorney information: Rebecca Liebowitz. Other appointed attorneys are Andrew Price, Halle Markus, Kristen Ruisi, Steven Powell, Marjorie Norman, Catherine Mitros, Paula Hopkins, Sean Phelan, Tanya Curcio, Renato Perez. Rebecca Liebowitz of VENABLE LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      P.O. Box 34385
      Washington, District of Columbia 20043
      United States
      202-344-4000(phone)
      202 344 8300(fax)
      trademarkdocket@venable.com
The docket/reference number is 60895-527289.
Rebecca Liebowitz submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Rebecca Liebowitz of VENABLE LLP
      P.O. Box 34385
      Washington District of Columbia 20043
      United States
      202-344-4000(phone)
      202 344 8300(fax)
      trademarkdocket@venable.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The applicant's current Correspondence Information:

Rebecca Liebowitz

PRIMARY EMAIL FOR CORRESPONDENCE: trademarkdocket@venable.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): rliebowitz@venable.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Payment Sale Number: 90130276
Payment Accounting Date: 08/21/2020

Serial Number: 90130276
Internet Transmission Date: Fri Aug 21 17:58:18 ET 2020
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-202008211758180
70822-90130276-74058cb52845525fd9742c996
52417a156b7d7f8d4b53b152e6da418d5ad1b939
2c-CC-58160793-20200821175048908665